Insiders · Profile

Shtylla Brunilda

Chief Business Officer at SUTRO BIOPHARMA. Filing since 25 Aug 2023. CIK 0001966915

Company
Date
Role
Action
Shares
Amount
Of holding
28 Aug 2023
Chief Business Officer
Sold at will
15,428
$72.59K
100%
25 Aug 2023
Chief Business Officer
Sold at will
11,613
$53.28K
47.3%
2 decisions on file.